Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mimran

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
European Journal of Immunology|April 13, 2000
Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNAJ Herkel, N Erez-Alon, A Mimran, et al.
Acta Physiologica Scandinavica|November 1, 1992
Renal interstitial pressure and tubuloglomerular feedback control in rats during infusion of atrial natriuretic peptide (ANP)P Morsing, A Stenberg, D Casellas, et al.
Nucleic Acids Research|January 29, 2002
Activation of p53 protein by telomeric (TTAGGG)n repeatsM Milyavsky, A Mimran, S Senderovich, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter studyT Hannedouche, J P Fillastre, A Mimran, et al.
Journal of Autoimmunity|August 8, 2001
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodiesJ Herkel, A Mimran, N Erez, et al.
Diabetes & Metabolism|February 1, 1996
[Arterial hypertension and diabetes. Members of the Board of Directors and Scientific Directors of ALFEDIAM]B Bauduceau, G Chatellier, D Cordonnier, et al.
American Journal of Hypertension|August 11, 2001
Endothelin gene variants and aortic and cardiac structure in never-treated hypertensivesM Lajemi, S Gautier, O Poirier, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)F R Bühler, G Berglund, O K Anderson, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Renin angiotensin aldosterone system, urinary prostaglandins and kallikrein in pregnancy induced hypertension. Evidence for a disregulation of the renin-angiotensin-prostacyclin loopP Fievet, A Fournier, E Agnes, et al.
Journal of Human Hypertension|December 15, 2010
Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)A Januszewicz, E Ritz, G Viberti, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
European Journal of Immunology|April 13, 2000
Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNAJ Herkel, N Erez-Alon, A Mimran, et al.
Acta Physiologica Scandinavica|November 1, 1992
Renal interstitial pressure and tubuloglomerular feedback control in rats during infusion of atrial natriuretic peptide (ANP)P Morsing, A Stenberg, D Casellas, et al.
Nucleic Acids Research|January 29, 2002
Activation of p53 protein by telomeric (TTAGGG)n repeatsM Milyavsky, A Mimran, S Senderovich, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter studyT Hannedouche, J P Fillastre, A Mimran, et al.
Journal of Autoimmunity|August 8, 2001
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodiesJ Herkel, A Mimran, N Erez, et al.
Diabetes & Metabolism|February 1, 1996
[Arterial hypertension and diabetes. Members of the Board of Directors and Scientific Directors of ALFEDIAM]B Bauduceau, G Chatellier, D Cordonnier, et al.
American Journal of Hypertension|August 11, 2001
Endothelin gene variants and aortic and cardiac structure in never-treated hypertensivesM Lajemi, S Gautier, O Poirier, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)F R Bühler, G Berglund, O K Anderson, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Renin angiotensin aldosterone system, urinary prostaglandins and kallikrein in pregnancy induced hypertension. Evidence for a disregulation of the renin-angiotensin-prostacyclin loopP Fievet, A Fournier, E Agnes, et al.
Journal of Human Hypertension|December 15, 2010
Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)A Januszewicz, E Ritz, G Viberti, et al.
Pageof 27